Ani Pharmaceuticals Inc (ANIP)

CapEx to Revenue

4.26%

Quarterly · Period ending:

ANIP logo

ANIP CapEx to Revenue

Latest reported4.26%
ANIP Quarterly CapEx/Revenue (0.00% → 4.26%)
High-resolution chart · PNG

ANIP capex to revenue history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Ani Pharmaceuticals Inc CapEx to Revenue — Quarterly
Period endingCapEx to Revenue
40.1727%
0%
0%
0%
0%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.